Pediatric arteriovenous malformations: a 15-year experience with an emphasis on residual and recurrent lesions

Paul Klimo1, Ganesh Rao, Douglas Brockmeyer

  • 1Department of Neurosurgery, University of Utah, Primary Children's Medical Center, 100 N. Medical Drive, Salt Lake City, UT 84113, USA.

Insights

Microsurgical resection effectively treats pediatric arteriovenous malformations (AVMs), achieving high obliteration rates. Diffuse-type AVMs present greater challenges, with higher risks of residual disease and recurrence.

Area of Science:

  • Neurosurgery
  • Pediatric Neurology
  • Vascular Malformations

Background:

  • Pediatric arteriovenous malformations (AVMs) require effective treatment strategies.
  • Microsurgical resection is the primary approach for pediatric AVMs.
  • Understanding outcomes for residual or recurrent AVMs is crucial.

Observation:

  • A 15-year review of 39 pediatric AVM patients (average age 10.3 years) was conducted.
  • The study analyzed AVM obliteration, residual lesions, and recurrence rates.
  • Mean follow-up was 30 months.

Findings:

  • The overall long-term AVM obliteration rate was 89% following microsurgical resection.
  • 23% of patients had residual AVMs after initial treatment, with 5 undergoing successful further treatment.
  • 13% experienced recurrence within 6 years, particularly those with diffuse-type AVMs.

Implications:

  • Microsurgical resection is a successful primary treatment for most pediatric AVMs.
  • Endovascular and stereotactic radiosurgery serve as adjunct or alternative treatments.
  • Diffuse-type AVMs require careful management due to higher recurrence and residual rates.
Abstract